In a significant bust, Thai customs officials arrested a Chinese man at Suvarnabhumi International Airport in Bangkok this week, uncovering an astonishing 8,900 unregistered “GLP-1” weight loss injection pens—commonly referred to as “skinny needles”—in his luggage. The total estimated value of these products is over 5.34 million Thai baht, which is approximately 158,000 US dollars.
According to the Director of the Passenger Control Customs Office at Suvarnabhumi Airport, Santanee Phairattanakorn, the man arrived in Thailand on Saturday, October 31, after taking a flight from Dhaka, the capital of Bangladesh. During the inspection of his two suitcases, customs officials discovered a significant quantity of weight loss pens sealed in plastic bags.
The customs department later confirmed the case on November 1 through an official post on their Facebook page, announcing that the man suspected of acting as a smuggler had been detained and handed over to the police for prosecution in accordance with the law.
Supattra Boonserm, the Secretary-General of the Thai Food and Drug Administration (FDA), clarified that the seized injection pens are categorized as GLP-1 receptor agonists, which include medications such as Liraglutide and Semaglutide. Originally designed for the treatment of type 2 diabetes, these drugs are noted for their effects of slowing gastric emptying and enhancing feelings of satiety, which has led to their frequent misuse for weight management.
However, the Thai government has recently taken stringent measures regarding the use of such drugs. Following a surge in cases of individuals using these medications for weight loss without appropriate medical assessment and supervision, the government classified these substances as “controlled drugs” as of September 15, 2026. This regulation mandates that they can only be sold with a physician’s prescription in pharmacies.
Customs authorities have underscored the serious violation associated with the unauthorized attempt to bring these products into the country, noting that it contravenes Thailand’s 2017 Customs Act as well as drug laws amended in 1967.
Reports indicate that this incident is not the first of its kind at the airport. In May of this year, customs officials also apprehended another Chinese traveler from Bangladesh, who was found with 137 packages of Tirzepatide, another medication utilized for diabetes treatment and weight loss, valued at 2.13 million baht.
Additionally, authorities have recently uncovered various illegal activities involving Chinese nationals at both Bangkok’s Suvarnabhumi and Don Mueang airports, including attempts to smuggle methamphetamine disguised as snacks and incidents of theft from passengers on board.
The rising trend of such offenses has prompted tighter security measures to ensure compliance with laws governing drug control and smuggling. This latest case serves as a stark reminder of the complexities and dangers associated with the booming market for unregulated weight loss products in Thailand and the ongoing efforts to combat illegal drug trafficking.